Opus Genetics, Inc.
NASDAQ:IRDBiotechnology
Healthcare
$3.92 -0.12%
-$0.01 today
- Market cap
- $326.13M
- Beta
- 0.55
- P/E (TTM)
- -33.0
- EPS (TTM)
- -$0.12
52W Low $0.90High $5.81
Volume 0.75M
Average 0.81M
Balance Sheet
Inspect the capital base behind the business.
Assets
$50.24M
FY 2025 · Annual
+36.3% YoYLiabilities
$34.90M
FY 2025 · Annual
+15.8% YoYEquity
$15.35M
FY 2025 · Annual
+128.3% YoYBalance Sheet
USD
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $60.0M |
| Receivables | $2.7M |
| Other Current | $3.9M |
| Total Current Assets | $66.6M |
| PP&E (Net) | $186.0K |
| Total Non-current Assets | $186.0K |
| Total Assets | $66.8M |
Analysis
Selected assets total $66.8M for Latest. The largest visible component is Cash & Equivalents at $60.0M, about 89.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 12, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 27, 2026 |
How much cash does IRD have?
Opus Genetics, Inc. (IRD) reported $45.09M in cash and equivalents in fiscal 2025.
How much debt does IRD carry?
Opus Genetics, Inc. (IRD) reported $0.00 of total debt, with net debt of -$45.09M.
Continue the stock analysis
Jump to another research area for this company.